CPHI’s Post

All roads lead to Lagos, #Nigeria, for the Industry Engagement “Access to Health Innovation” Forum. Join us for discussions focusing on accelerating equitable access to quality-assured pharmaceutical products and services through building sustainable regional health value chains. In attendance will be major stakeholders within the global health ecosystem, including West African Pharmaceutical Manufacturers Association (WAPMA), World Health Organization, the Medicines Patent Pool, The Global Fund, USAID, PEPFAR, UNICEF, global and regional pharmaceutical manufacturers, research and development networks, the Federation of African Manufacturers’ Associations, Africa CDC -- regulatory agencies and foundations working on access to medicines and diagnostics, AUDA-NEPAD, communities, and civil society organizations. The African Development Bank, the IFC - International Finance Corporation and Unitaid will host the Industry Engagement “Access to Health Innovation” Forum. Learn more and join us: https://bit.ly/3Qp5d4G

We are proud to continue leading this important platform for dialogue between Uzbekistan state authorities and European companies and organizations in the interests of better healthcare system of Uzbekistan. In addition to discussing 2024 goals of The Europe-Uzbekistan Association for Economic Cooperation — EUROUZ Healthcare & Life Sciences Committee, our partner Zafar Vakhidov has summarized updates in healthcare and pharma regulations and structure, which we constantly monitor at Vakhidov & Partners. #change #leadingtheway #healthcare #pharma #medicaldevices #medical #medicalequipment #prices #eu #lifesciences #Uzbekistan #publicprocurement #medicalinsurance #intellectualproperty #counterfeit #unfaircompetition #brandmimicking #trademarks #medicines

Europe presents a significant opportunity for international biotech’s developing and commercialising rare and orphan medicines. With the EMA’s increasing focus on Real-World Data in its regulatory processes, there are several ways in which applying it can help speed up access to the European market. Download this exclusive guide to discover how Real-World Data can improve your chance of success in this complex market. https://lnkd.in/eaS6NKPf #raredisease #realworlddata #orphandrugs

On April 7, World Health Day is celebrated in honor of the creation of the World Health Organization 🩺 📌 According to WHO, health as a human right is mentioned in the constitutions of 140 countries. The Constitution of Belarus guarantees not just the right to health care, but also free treatment at public expense. Health is not a human right only but a business also. Revenue of the worldwide pharmaceutical market is about $1.5 trillion. It is worth noting that there is still enough room for new investment projects in the pharmaceutical market of Belarus. See review: https://lnkd.in/dKju5jdZ 😊 #investinbelarus #NAIP World Health Organization

We're proud to highlight the significant progress made by the Government of the Republic of Cameroon in combating #AntimicrobialResistance (AMR) through the implementation of a One Health platform! From 2019 to 2023, Cameroon has made great strides in strengthening its multisectoral coordination bodies, now operational and meeting regularly. These bodies, including the #InfectionPrevention and Control and Antimicrobial Stewardship Technical Working Groups, have been crucial in developing the new National Action Plan on #AMR. USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program has been a key partner in these efforts, supporting the establishment of robust governance structures to ensure effective multisectoral coordination. Sustainability will be achieved through formalized leadership, long-term domestic funding commitments, and engagement with a broader set of stakeholders to advance the #OneHealth approach. This will ensure the ongoing containment of AMR at both national and local levels and lead to saved lived and a healthier future for Cameroon and beyond» https://lnkd.in/eSV5vuDB

Some insights came up in this video for analyzing this situation happening in Africa and how handling it . #Pharma #Medicines

The Regulatory Affairs Networking Cocktail Theme: The World Health Organization Global Benchmarking Tool Assessment of National Medicines Regulatory Authorities (NMRAs) and its Role in Pharmaceutical Systems Strengthening. Access to safe, quality and efficacious medicines for all in the African continent is still a vision awaiting realization. The health security of Africa is still challenged by diseases which can be prevented or treated with timely access to appropriate and affordable medicines, vaccines and other health services, yet stringent regulatory policies present challenges to access to medicines. In response to regulatory challenges, a number of regional harmonization efforts have been introduced by African Union through the African Medicines Regulatory Harmonization (AMRH) initiative. We also acknowledge the use of the WHO global benchmarking tool (GBT), a primary means by which WHO assesses regulatory systems for the regulation of medical products. Drawing from this, we have curated the Regulatory Affairs Networking Cocktail, where stakeholders come together for the purpose of working together towards a common goal, how can more African NMRAs adopt and benefit from the use of the WHO GBT? Join us on August 9, 2024 at The Concord Hotels, Beach Villas, and Game Lodges for an engaging & enlightening Networking Cocktail. Register: https://lnkd.in/dGPbnD_j #PharmaceuticalSystemsStrengthening

🚀 Webinar: Creating a South African Medical Cannabis Country Competitive Strategy 🌱 📅 Date: 27 August 2024 🕖 Time: 19:00 (SAST) The global medical cannabis industry is evolving, and there’s a growing debate around outdoor cultivation, the relevance of EU GMP frameworks, and Africa's role in this space. Thanks to Trenton Birch and Linda Siboto from Cheeba Africa to let us unpack and assess how South Africa can develop a winning competitive strategy in this dynamic environment. 🔊 Panelists: Rob S. (Avitas Consulting / Global Cannabis Exchange, Canada/Portugal) Zaid Mohidin (Vitacann Pharm, South Africa) Daniel Simkin Kunisch (Trade Green Consulting / Cheeba Cannabis Consulting, Spain/Germany) Edgar Adams (Medigrow, South Africa) Ayanda Bam (Texttan / Zageta Solutions, South Africa) This is a complex and evolving discussion that demands focus and analysis. At Valenveras, we believe that the integration of advanced Near-Infrared (NIR) spectroscopy through Neospectra from Si-Ware Systems, combined with our customized models, can revolutionize the cannabis industry in South Africa. 🔗 Register here: https://lnkd.in/drRHTAgK #CannabisIndustry #SouthAfrica #Webinar #Valenveras #Innovation #FutureOfCannabis

I was thrilled to be part of such crucial first step towards a Critical Medicines Act. Indeed, we need to complement the #PharmaLegislation with a strong toolkit to tackle #medicineShortages that are adversely affecting patients across Europe. Under the auspices of the European Commission President Ursula von der Leyen the Belgian Presidency of the Council of the European Union 2024 led by Frank Vandenbroucke, Deputy Prime Minister and Minister of Social Affairs and Public Health, along with Commissioner for Health Stella Kyriakides and EU 27 Ministers of Health, the EU #CriticalMedicinesAlliance was officially launched. 15 CEOs representing Medicines for Europe presented our comprehensive approach to secure medicine supplies: 💊 A concrete shortage prevention strategy that includes EU medicines procurement guidelines rewarding security of medicine supply as well as the use of existing IT systems to predict and prevent shortages (such as the serialization system). 🤝 Collaboration between the EU and industry to enhance EU manufacturing competitiveness through digital and environmental innovations in production technologies. This can be facilitated through State Aids and IPCEI initiatives for off-patent medicines. 🔓 Concrete EU 27 solidarity should be our health mantra to deliver equity of access across EU Member States. We must avoid national stockpiling mandates, as they could result in oversupply in larger countries and shortage risks in smaller ones. According to the IQVIA MIDAS database, the German 6-months stockpile is equal to 10 Member Staes annual consumption and stockpile combined (see infographic below). We are ready to further collaborate with EU Institution, Member States and health stakeholders. Action is needed now! 💪🏼 #MedsSecurity #AccessEquity #LevelUP #EUhealthUnion #EUsolidarity #EU2024BE

The AMRH Secretariat invites Expression of Interests (EoIs) from experts in BA/BE assessments, CRO inspections and research to be members of the continental TWG on BA/BE requirements. The scope of assignment for the working group members shall be to harmonize BE requirements based on internationally accepted standards for adoption by countries across Africa and categorize complex and priority products that are best reviewed at the level of NRAs, RECs, or AMA including preparing and publishing list of acceptable comparator products for BE studies for Africa's priority medicines. Further details and specifics are outlined in the attached terms of reference. https://lnkd.in/dYKiXtUi